A detailed history of Ellevest, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Ellevest, Inc. holds 8,737 shares of BMY stock, worth $504,649. This represents 0.03% of its overall portfolio holdings.

Number of Shares
8,737
Previous 8,880 1.61%
Holding current value
$504,649
Previous $368,000 22.83%
% of portfolio
0.03%
Previous 0.02%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$39.66 - $51.75 $5,671 - $7,400
-143 Reduced 1.61%
8,737 $452,000
Q2 2024

Aug 14, 2024

BUY
$40.25 - $52.99 $7,486 - $9,856
186 Added 2.14%
8,880 $368,000
Q1 2024

May 13, 2024

BUY
$47.98 - $54.4 $4,126 - $4,678
86 Added 1.0%
8,694 $471,000
Q4 2023

Feb 06, 2024

SELL
$48.48 - $57.85 $56,430 - $67,337
-1,164 Reduced 11.91%
8,608 $441,000
Q3 2023

Nov 09, 2023

SELL
$57.89 - $64.73 $17,598 - $19,677
-304 Reduced 3.02%
9,772 $567,000
Q2 2023

Aug 09, 2023

BUY
$63.71 - $70.74 $40,392 - $44,849
634 Added 6.71%
10,076 $644,000
Q1 2023

May 04, 2023

SELL
$65.71 - $74.53 $218,945 - $248,333
-3,332 Reduced 26.08%
9,442 $654,000
Q4 2022

Feb 03, 2023

BUY
$68.48 - $81.09 $73,821 - $87,415
1,078 Added 9.22%
12,774 $918,000
Q3 2022

Nov 02, 2022

BUY
$0.13 - $76.84 $63 - $37,805
492 Added 4.39%
11,696 $831,000
Q2 2022

Jul 18, 2022

BUY
$72.62 - $79.98 $83,730 - $92,216
1,153 Added 11.47%
11,204 $863,000
Q1 2022

Apr 19, 2022

BUY
$61.48 - $73.72 $158,003 - $189,460
2,570 Added 34.35%
10,051 $734,000
Q4 2021

Jan 24, 2022

BUY
$53.63 - $62.52 $252,436 - $294,281
4,707 Added 169.68%
7,481 $466,000
Q3 2021

Oct 19, 2021

BUY
$59.17 - $69.31 $10,058 - $11,782
170 Added 6.53%
2,774 $164,000
Q2 2021

Jul 13, 2021

BUY
$61.91 - $67.42 $22,659 - $24,675
366 Added 16.35%
2,604 $174,000
Q1 2021

May 03, 2021

SELL
$59.34 - $66.74 $10,562 - $11,879
-178 Reduced 7.37%
2,238 $141,000
Q4 2020

Feb 04, 2021

BUY
$57.74 - $65.43 $16,686 - $18,909
289 Added 13.59%
2,416 $150,000
Q3 2020

Oct 26, 2020

BUY
$57.43 - $63.64 $4,594 - $5,091
80 Added 3.91%
2,127 $128,000
Q2 2020

Jul 06, 2020

BUY
$54.82 - $64.09 $27,410 - $32,045
500 Added 32.32%
2,047 $120,000
Q1 2020

Apr 13, 2020

SELL
$46.4 - $67.43 $1,392 - $2,022
-30 Reduced 1.9%
1,547 $86,000
Q4 2019

Feb 05, 2020

BUY
$49.21 - $64.19 $66,679 - $86,977
1,355 Added 610.36%
1,577 $101,000
Q3 2019

Oct 08, 2019

SELL
$42.77 - $50.71 $39,091 - $46,348
-914 Reduced 80.46%
222 $11,000
Q2 2019

Aug 20, 2019

BUY
$44.62 - $49.34 $50,688 - $56,050
1,136 New
1,136 $52,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Ellevest, Inc. Portfolio

Follow Ellevest, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ellevest, Inc. with notifications on news.